Novartis: Q3 Earnings Snapshot
Published . Updated .
Covered by 2 outlets: kens5.com, Yahoo Finance.
Who covered it: Center 1 · Not rated 1. How we rate outlets
BASEL, Switzerland (AP) — BASEL, Switzerland (AP) — Novartis AG (NVS) on Tuesday reported third-quarter profit of $1.On a per-share basis, the Basel, Switzerland-based company said it had net income of 63 cents.
Directly affected
- NVS Novartis Ag+1.3% 17d
Named in this report.
Indirectly affected
- EWL iShares MSCI Switzerland ETF
iShares MSCI Switzerland ETF holds stocks listed in Switzerland, which this story is about (“switzerland”).
- EFA iShares MSCI EAFE ETF-2.2% 11d
iShares MSCI EAFE ETF is a broad fund of developed-market stocks that includes Switzerland, which this story is about.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Novartis AG belongs to, so it often moves with news about it.
- AZN AstraZeneca+4.7% 30d
AstraZeneca is a peer of Novartis AG in pharmaceutical preparations; rivals often move on the same news.
- NVO Novo Nordisk A/S-10.2% 30d
Novo Nordisk A/S is a peer of Novartis AG in pharmaceutical preparations; rivals often move on the same news.
- GSK Gsk-6.3% 10d
Gsk is a peer of Novartis AG in pharmaceutical preparations; rivals often move on the same news.
- SNY Sanofi
Sanofi is a peer of Novartis AG in pharmaceutical preparations; rivals often move on the same news.
- ROIV Roivant Sciences
Roivant Sciences is a peer of Novartis AG in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| NVSNo price data for this ticker | — | — | — | — | — | — | — |
| EWLNo price data for this ticker | — | — | — | — | — | — | — |
| EFANo price data for this ticker | — | — | — | — | — | — | — |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| AZNNo price data for this ticker | — | — | — | — | — | — | — |
| NVONo price data for this ticker | — | — | — | — | — | — | — |
| GSKNo price data for this ticker | — | — | — | — | — | — | — |
| SNYNo price data for this ticker | — | — | — | — | — | — | — |
| ROIVNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Novartis: Q3 Earnings Snapshot kens5.com
Source: kens5.com
Congressional trades in the stocks in this story
- Rep. Kevin Hern sold Novartis Ag (NVS), worth $15,001 - $50,000 on 27 Aug 2026. That is 61 days before publication. Filed 25 Sep 2026. View the filing.
- Sen. John Boozman sold EFA (jointly held), worth $1,001 - $15,000 on 9 Sep 2026. That is 48 days before publication. Filed 21 Oct 2026. View the filing.
- Rep. Kevin Hern sold Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 10 Sep 2026. That is 47 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 31 Aug 2026. That is 57 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Scott Scott Franklin bought Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 26 Aug 2026. That is 62 days before publication. Filed 17 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
How solid “Novartis: Q3 Earnings Snapshot” looks
25 out of 100
“Novartis: Q3 Earnings Snapshot” scores 25 out of 100. The score uses 2 sources.